Thursday, February 12, 2015

Ziopharma Oncology - Barchart's Chart of the Day

Ziopharma Oncology (ZIOP) is the Barchart Chart of the Day. The medical out patient services company has a Trend Spotter buy signal, a Weighted Alpha of 117.70+ and gained 125.00% in the last year.

The Chart of the Day belongs to Ziopharm Oncology (ZIOP). I found the stock by sorting the All Time High list for the stocks with the best technical buy signals, then used the Flipchart feature to review the charts.  Since the Trend Spotter signaled a buy on 10/24 the stock gained 308.33%

ZIOP is a biopharmaceutical company engaged in the development and commercialization of a diverse, risk-sensitive portfolio of in-licensed cancer drugs to address unmet medical needs. The Company applies new insights from molecular and cancer biology to understand the efficacy and safety limitations of approved and developmental cancer therapies and identifies proprietary and related molecules for better patient treatment.


Barchart's Opinion trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com web site when you read this report.

Barchart technical indicators:

  • 100% Barchart technical buy signals
  • Trend Spotter buy signal
  • Above its 20, 50 and 100 day moving averages
  • 5 new highs and up 68.47% in the last month
  • Relative Strength Index 72.57%
  • Barchart computes a technical support level at 8.67
  • Recently traded at 9.99 with a 50 day moving average of 6.24
Fundamental factors:
  • Market Cap $1.01 billion
  • Revenue expected to grow 37.50% this year
  • Earnings estimated to increase 39.40% this year
  • Wall Street analysts issued 1 strong buy, 2 buy and 1 hod recommendation on the stock
  • On Motley Fool the individual investor voted 90 to 19 that the stock will beat the market
This is a very volatile and speculative issue.  If you're not in already I would not advise trying to get in at this level and if you own it you better have a moving stop loss in place because it can fall just as quickly as it rose.

No comments:

Post a Comment